Emerging small molecule antivirals may fit neatly into COVID-19 treatment
Caroline Fenton, Susan J. Keam
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Intensive care medicineRitonavirClinical trialPharmacySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseAntiviral therapyPharmacologyInternal medicineHuman immunodeficiency virus (HIV)VirusVirologyInfectious disease (medical specialty)Viral loadAntiretroviral therapyFamily medicineOutbreakChronic hepatitisCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19